Hasil Pencarian - Parvaneh Vossough

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia

    Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia oleh Gholamreza Bahoush, Mardavizh Albouyeh, Parvaneh Vossough

    Diterbitkan 2009-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia

    Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia oleh Gholamreza Bahoush, Mardavizh Albouyeh, Parvaneh Vossough

    Diterbitkan 2009-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Epidemiological Features of Childhood Acute Leukemia at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran

    Epidemiological Features of Childhood Acute Leukemia at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran oleh Azim Mehrvar, Mohammad Faranoush, Amir Abbas Hedayati Asl, Maryam Tashvighi, Mohammad Ali Fazeli, Narjes Mehrvar, Rokhsaneh Zangooie, Afarin Sadeghian, Ali Jafarpour, Behdad Sobuti, Mardawig Alebouyeh, Parvaneh Vossough

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Classifying Pediatric Central Nervous System Tumors through near Optimal Feature Selection and Mutual Information: A Single Center Cohort

    Classifying Pediatric Central Nervous System Tumors through near Optimal Feature Selection and Mutual Information: A Single Center Cohort oleh Mohammad Faranoush, Mohammad Torabi-Nami, Azim Mehrvar, Amir Abbas HedayatiAsl, Maryam Tashvighi, Reza Ravan Parsa, Mohammad Ali Fazeli, Behdad Sobuti, Narjes Mehrvar, Ali Jafarpour, Rokhsareh Zangooei, Mardawij Alebouyeh, Mohammadreza Abolghasemi, Abdol-Hossein Vahabie, Parvaneh Vossough

    Diterbitkan 2013-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: